X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (10350) 10350
Book Review (1503) 1503
Newsletter (932) 932
Publication (840) 840
Book Chapter (54) 54
Magazine Article (28) 28
Dissertation (21) 21
Conference Proceeding (18) 18
Book / eBook (13) 13
Data Set (2) 2
Newspaper Article (2) 2
Trade Publication Article (2) 2
Paper (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (9471) 9471
humans (6655) 6655
pharmacology & pharmacy (4494) 4494
animals (4377) 4377
cytochrome p-450 (4086) 4086
male (3888) 3888
cytochrome p-450 enzyme system - metabolism (3529) 3529
metabolism (2630) 2630
female (2547) 2547
toxicology (2345) 2345
cytochrome p450 (2263) 2263
rats (2223) 2223
physiological aspects (1783) 1783
enzymes (1676) 1676
liver (1557) 1557
cytochrome p-450 enzyme system - genetics (1515) 1515
microsomes, liver - enzymology (1470) 1470
cytochrome p-450 cyp1a2 - metabolism (1459) 1459
adult (1451) 1451
pharmacokinetics (1427) 1427
drug interactions (1403) 1403
in-vitro (1258) 1258
research (1249) 1249
biochemistry & molecular biology (1243) 1243
mice (1230) 1230
analysis (1206) 1206
middle aged (1206) 1206
liver - enzymology (1174) 1174
expression (1102) 1102
microsomes, liver - metabolism (1090) 1090
induction (1078) 1078
liver - drug effects (1002) 1002
microsomes, liver - drug effects (995) 995
metabolites (985) 985
liver - metabolism (909) 909
cytochrome p-450 cyp1a1 - metabolism (903) 903
cytochrome p-450 enzyme inhibitors (881) 881
inhibition (868) 868
biotransformation (864) 864
dose-response relationship, drug (850) 850
cytochrome p-450 cyp1a2 - genetics (844) 844
rats, sprague-dawley (822) 822
kinetics (797) 797
human liver-microsomes (794) 794
genotype (775) 775
cancer (771) 771
aged (748) 748
enzyme inhibitors - pharmacology (746) 746
cyp1a2 (731) 731
isoenzymes - metabolism (684) 684
hydroxylation (679) 679
cytochrome p-450 cyp3a (676) 676
genetic aspects (667) 667
cytochrome p-450 cyp1a1 - genetics (652) 652
cytochrome p-450 enzyme system - biosynthesis (650) 650
gene expression (649) 649
aryl hydrocarbon hydroxylases - metabolism (644) 644
pharmacogenetics (611) 611
oncology (609) 609
cytochrome (608) 608
pharmacology/toxicology (608) 608
cells, cultured (607) 607
cytochrome p-450 cyp3a - metabolism (604) 604
rat (601) 601
drugs (580) 580
drug metabolism (569) 569
cytochrome p-450 cyp1a2 (566) 566
polymorphism, genetic (565) 565
drug-metabolism (563) 563
toxicity (559) 559
rna, messenger - metabolism (547) 547
enzyme induction - drug effects (534) 534
enzyme induction (526) 526
gene-expression (525) 525
in vitro techniques (524) 524
rats, wistar (524) 524
pharmacology (516) 516
caffeine (508) 508
chromatography, high pressure liquid (508) 508
microsomes (501) 501
substrate specificity (493) 493
aryl hydrocarbon hydroxylases - genetics (491) 491
identification (475) 475
aryl hydrocarbon hydroxylases (471) 471
genes (471) 471
activation (470) 470
article (468) 468
chemistry, medicinal (467) 467
proteins (458) 458
oxidation (450) 450
phenotype (447) 447
health aspects (443) 443
polymorphism (442) 442
hepatocytes - drug effects (438) 438
universities and colleges (437) 437
cytochromes p450 (420) 420
cytochrome-p450 (419) 419
liver-microsomes (418) 418
area under curve (416) 416
cytochrome p-450 cyp2d6 - metabolism (416) 416
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (11231) 11231
Chinese (52) 52
Russian (33) 33
Japanese (14) 14
German (10) 10
Polish (8) 8
Spanish (8) 8
French (6) 6
Dutch (2) 2
Czech (1) 1
Finnish (1) 1
Hungarian (1) 1
Italian (1) 1
Norwegian (1) 1
Slovak (1) 1
Swedish (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Drug Metabolism and Disposition, ISSN 0090-9556, 01/2010, Volume 38, Issue 1, pp. 92 - 99
The aim of the current study is to identify the human cytochrome P450 (P450) isoforms involved in the two oxidative steps in the bioactivation of clopidogrel... 
MECHANISM-BASED INHIBITION | ANTIAGGREGATING ACTIVITY | POLYMORPHISMS | TICLOPIDINE | PHARMACOKINETICS | HEALTHY-SUBJECTS | PHARMACOLOGY & PHARMACY | PRASUGREL | PHARMACODYNAMICS | MONOCLONAL-ANTIBODIES | ATORVASTATIN | Microsomes - metabolism | Humans | Aryl Hydrocarbon Hydroxylases - genetics | Cytochrome P-450 Enzyme System - metabolism | Sulfaphenazole - pharmacology | Microsomes - drug effects | Cytochrome P-450 CYP3A - genetics | Cytochrome P-450 CYP1A2 - genetics | Antibodies - immunology | Omeprazole - pharmacology | Microsomes, Liver - enzymology | Platelet Aggregation Inhibitors - pharmacokinetics | Ticlopidine - pharmacokinetics | Oxidoreductases, N-Demethylating - metabolism | Aryl Hydrocarbon Hydroxylases - immunology | Oxidation-Reduction | Enzyme Inhibitors - pharmacology | Ticlopidine - analogs & derivatives | Oxidoreductases, N-Demethylating - immunology | Cytochrome P-450 CYP3A - metabolism | Cell Line, Tumor | Cytochrome P-450 Enzyme System - genetics | Theophylline - pharmacology | Kinetics | Cytochrome P-450 CYP2C9 | Theophylline - analogs & derivatives | Oxidoreductases, N-Demethylating - genetics | Glutathione - metabolism | Ketoconazole - pharmacology | Biotransformation - physiology | Cytochrome P-450 CYP1A2 Inhibitors | Microsomes, Liver - drug effects | Ticlopidine - metabolism | NADP - metabolism | Platelet Aggregation Inhibitors - metabolism | Cytochrome P-450 CYP3A - immunology | Cell Line | Aryl Hydrocarbon Hydroxylases - antagonists & inhibitors | Cytochrome P-450 CYP1A2 - immunology | Biocatalysis | Mephenytoin - analogs & derivatives | Cytochrome P-450 CYP1A2 - metabolism | Aryl Hydrocarbon Hydroxylases - metabolism | Mephenytoin - pharmacology | Antibodies - pharmacology | Cytochrome P-450 CYP3A Inhibitors | Cytochrome P-450 CYP2C19 | Clopidogrel | Cytochrome P-450 CYP2B6 | Index Medicus
Journal Article
Journal Article
Drug Metabolism and Disposition, ISSN 0090-9556, 08/2016, Volume 44, Issue 8, pp. 1217 - 1228
Journal Article
PLoS ONE, ISSN 1932-6203, 07/2015, Volume 10, Issue 7, pp. e0132992 - e0132992
Human pluripotent stem cell-derived hepatocytes have the potential to provide in vitro model systems for drug discovery and hepatotoxicity testing. However,... 
DNA METHYLATION | HUMAN LUNG | QUANTIFICATION | MULTIDISCIPLINARY SCIENCES | PLACENTA | HUMAN LIVER | HUMAN CYP1A1 | MECHANISMS | CYP2E1 | DIFFERENTIATION | EXPRESSION | Chromatin - metabolism | Cytochrome P-450 CYP1A1 - genetics | Cytochrome P-450 CYP1B1 - genetics | Epigenesis, Genetic | Human Embryonic Stem Cells - cytology | Humans | Cytochrome P-450 CYP1B1 - metabolism | Cytochrome P-450 CYP2E1 - genetics | Cytochrome P-450 CYP2E1 - metabolism | Hepatocytes - metabolism | DNA Methylation | Hepatocytes - cytology | Cytochrome P-450 CYP1A2 - genetics | Transcription, Genetic | Cell Differentiation | Chromatin - ultrastructure | Cell Line | Cytochrome P-450 CYP2D6 - genetics | Human Embryonic Stem Cells - metabolism | DNA Modification Methylases - metabolism | Histone Deacetylases - genetics | Signal Transduction | Histone Deacetylases - metabolism | Cytochrome P-450 CYP1A1 - metabolism | Organ Specificity | Cytochrome P-450 CYP1A2 - metabolism | DNA Modification Methylases - genetics | Histones - genetics | CpG Islands | Cytochrome P-450 CYP2D6 - metabolism | Protein Processing, Post-Translational | Histones - metabolism | Primary Cell Culture | Epigenetic inheritance | Methylation | Embryonic stem cells | Genes | Cytochrome P-450 | Cytochrome | Chromatin | Transcription | Toxicity | Gene regulation | Liver | Science | Demethylation | Rodents | Toxicity testing | DNA methylation | Inhibition | Hepatotoxicity | CYP2D6 protein | Deoxyribonucleic acid--DNA | CpG islands | Enzymes | Cytochrome P450 | CYP1A2 protein | Gene expression | Hepatocytes | Stem cells | Pluripotency | Combinatorial analysis | Index Medicus | Deoxyribonucleic acid | DNA
Journal Article
Molecular and Cellular Biochemistry, ISSN 0300-8177, 6/2014, Volume 391, Issue 1, pp. 127 - 136
Incense smoke is increasingly being recognized as a potential environmental contaminant and is linked to malignant and non-malignant respiratory diseases. The... 
Life Sciences | Biochemistry, general | Cytochrome p-450 | Oxidative stress | Lung | Liver | Incense | Medical Biochemistry | Oncology | Inflammation | Cardiology | PARTICLES | POLYCYCLIC AROMATIC-HYDROCARBONS | RISK | DNA ADDUCT FORMATION | CELL BIOLOGY | HEPATOCELLULAR-CARCINOMA | ORGANIC EXTRACTS | CIGARETTE-SMOKE | AIR-POLLUTANTS | EXPRESSION | PARTICULATE MATTER | Tumor Necrosis Factor-alpha - metabolism | Cytochrome P-450 CYP1A1 - genetics | Cytochrome P-450 CYP1B1 - genetics | Inflammation - pathology | Liver - pathology | Liver - enzymology | Rats, Wistar | Cytochrome P-450 CYP1B1 - metabolism | Male | RNA, Messenger - metabolism | Cytochrome P-450 CYP1B1 - biosynthesis | Lung - enzymology | Organ Specificity - genetics | Cytochrome P-450 CYP1A2 - genetics | Biomarkers - metabolism | Lung - pathology | Smoke - adverse effects | Interleukin-4 - metabolism | RNA, Messenger - genetics | Oxidative Stress - genetics | Enzyme Induction | Cytochrome P-450 CYP1A1 - metabolism | Cytochrome P-450 CYP1A2 - metabolism | Environmental Exposure - adverse effects | Animals | Cytochrome P-450 CYP1A2 - biosynthesis | Perfume - adverse effects | Cytochrome P-450 CYP1A1 - biosynthesis | Inflammation - enzymology | Metabolites | Polycyclic aromatic hydrocarbons | DNA | Cytochrome P-450 | Enzymes | Biochemistry | DNA damage | Index Medicus
Journal Article
International Journal of Nanomedicine, ISSN 1176-9114, 2018, Volume 13, pp. 8561 - 8575
Introduction and objective: Currently, carbon nanostructures are vastly explored materials with potential for future employment in biomedicine. The possibility... 
Nanoparticles | Carbon nanostructures | Cytochrome p450 | Liver | Microsomes | liver | POLYCYCLIC AROMATIC-HYDROCARBONS | NANOMATERIALS | NANOSCIENCE & NANOTECHNOLOGY | TOXICITY | carbon nanostructures | cytochrome P450 | INDUCTION | DRUG-METABOLIZING-ENZYMES | WALLED CARBON NANOTUBES | nanoparticles | HEPG2 CELLS | PHARMACOLOGY & PHARMACY | EXPRESSION | CYTOCHROME-P450 ENZYME | microsomes | Cytochrome P-450 CYP2D6 - genetics | Nanostructures - ultrastructure | Cytochrome P-450 Enzyme Inhibitors | Cell Survival | Humans | Liver - metabolism | Cytochrome P-450 Enzyme System - metabolism | Fluorescence | Hydrodynamics | Hepatocytes - metabolism | Diamond - chemistry | Cytochrome P-450 CYP1A2 - metabolism | Down-Regulation - genetics | Hep G2 Cells | Cytochrome P-450 CYP3A - genetics | Cytochrome P-450 CYP3A - metabolism | Isoenzymes - metabolism | Cytochrome P-450 CYP1A2 - genetics | Cytochrome P-450 CYP2D6 - metabolism | Cytochrome P-450 Enzyme System - genetics | Nanostructures - chemistry | Graphite - chemistry | Cytochrome P-450 Enzyme System - pharmacology | Hepatocytes - drug effects | Diamond crystals | RNA | Isoenzymes | Graphene | Genes | Cytochrome P-450 | Diamonds | Graphite | Genetic research | Genetic aspects | Gene expression | Cytochrome | Enzymes | Drug delivery systems | Nanomaterials | Metabolism | Carbon | Drug dosages | Index Medicus
Journal Article
Journal Article
Basic & Clinical Pharmacology & Toxicology, ISSN 1742-7835, 09/2016, Volume 119, Issue 3, pp. 284 - 290
Cytochrome P450 ( CYP ) activity can be assessed using a ‘cocktail’ phenotyping approach. Recently, we have developed a cocktail (Geneva cocktail) which... 
2D6 | PARAXANTHINE | BUPROPION | IN-VIVO | PHARMACOLOGY & PHARMACY | TOXICOLOGY | FLURBIPROFEN | METABOLIZING-ENZYMES | COOPERSTOWN 5+1 COCKTAIL | ORAL-CONTRACEPTIVES | P-GLYCOPROTEIN | Caffeine - administration & dosage | Humans | Midazolam - administration & dosage | Male | Genotyping Techniques | Cytochrome P-450 CYP2B6 - metabolism | Terfenadine - administration & dosage | Caffeine - pharmacokinetics | Dose-Response Relationship, Drug | Young Adult | Drug Interactions | Cytochrome P-450 CYP3A - genetics | Dried Blood Spot Testing - methods | Cytochrome P-450 CYP1A2 - genetics | Flurbiprofen - administration & dosage | Adult | Female | Dextromethorphan - pharmacokinetics | Cytochrome P-450 CYP2C9 - metabolism | Terfenadine - pharmacokinetics | Bupropion - pharmacokinetics | Cytochrome P-450 CYP2D6 - genetics | Flurbiprofen - pharmacokinetics | Cytochrome P-450 CYP2B6 - genetics | Omeprazole - administration & dosage | Cytochrome P-450 CYP2C19 - genetics | Terfenadine - analogs & derivatives | Omeprazole - pharmacokinetics | Midazolam - pharmacokinetics | Cytochrome P-450 CYP1A2 - metabolism | Bupropion - administration & dosage | Cytochrome P-450 CYP2C9 - genetics | Cross-Over Studies | Phenotype | Cytochrome P-450 CYP3A - metabolism | Adolescent | Cytochrome P-450 CYP2D6 - metabolism | Cytochrome P-450 Enzyme System - genetics | Cytochrome P-450 CYP2C19 - metabolism | Dextromethorphan - administration & dosage | Medical examination | Drug interactions | Analysis | Methods | Blood | Cytochrome P-450 | Confidence intervals | Cytochrome | Prescription drugs | Drug dosages | Index Medicus
Journal Article
Journal Article
Journal Article
Drug metabolism and disposition: the biological fate of chemicals, ISSN 0090-9556, 2015, Volume 43, Issue 6, pp. 819 - 828
Journal Article
Life Sciences, ISSN 0024-3205, 12/2017, Volume 190, pp. 46 - 51
Journal Article
Food and Chemical Toxicology, ISSN 0278-6915, 12/2017, Volume 110, pp. 383 - 394
Natural flavonoids with methoxy substitutions are metabolized by CYP1 enzymes to yield the corresponding demethylated products. The present study aimed to... 
Antiproliferation | Flavonoids | Cytochrome P450 CYP1 enzy